Research LettersEffect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis
References (5)
- et al.
Prevention of chronic Pseudomonas aeruginosa colonisation by early treatment
Lancet
(1991) Cystic Fibrosis Foundation Patient Registry annual report 1998
(1999)
There are more references available in the full text version of this article.
Cited by (204)
Scope and limitations on aerosol drug delivery for the treatment of infectious respiratory diseases
2020, Journal of Controlled ReleaseA shell-less hen's egg test as infection model to determine the biocompatibility and antimicrobial efficacy of drugs and drug formulations against Pseudomonas aeruginosa
2020, International Journal of PharmaceuticsEarly detection using qPCR of Pseudomonas aeruginosa infection in children with cystic fibrosis undergoing eradication treatment
2018, Journal of Cystic FibrosisCitation Excerpt :Therefore, antibiotic eradication therapy (AET) is often attempted in patients with early Pa infections [3–5]. Tobramycin inhaled solution (TIS) is frequently used for AET, given its safety and efficacy profile [4–6]. However, AET fails in about 10–40% of cases [7].
Copyright © 2001 Elsevier Ltd. All rights reserved.